Bringing the fundamentals into focus…
Back to Cronos Group Inc.
How Cronos Group Inc. stacks up
CRON · against 453 other Healthcare companies of similar size
Valuation
61/ 100
Above the middle of the pack.
Ranked #190 of 454 · scores higher than 57% of peers
Bars: peers in each 10-point band of the valuation score43 peers with a valuation score of 60–69, including CRON · Click a bar to see the companies
Why valuation scores 61?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its earnings yield and free cash flow yield, which are stronger than most Healthcare peers.
- EBITDA yield is close to the peer norm. EBITDA yield: 2.4% vs peer median 4.0%
- more free cash flow for the price paid: stronger than 73% of peers. Free cash flow yield: 4.0% vs peer median 0.0%
- higher earnings for the price paid: stronger than 82% of peers. Earnings yield: 5.6% vs peer median 1.5%
Metric by metric
Position: dot = CRON, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | CRON | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 444 reported | 5.6% | 1.4% | 81% | 30% | |
| EBITDA yieldHigher is better · 457 reported | 2.4% | 4.3% | 41% | 50% | |
| Free cash flow yieldHigher is better · 209 reported | 4.0% | -1.6% | 74% | 20% | |
| Book yieldHigher is better · 449 reported | 85.3% | 40.4% | 86% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around CRONScores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score